CVIR Endovasc. 2021 Apr 17;4(1):36. doi: 10.1186/s42155-021-00226-6.
Management and endovascular therapy of ureteroarterial fistulas: experience from a single center and review of the literature.
CVIR endovascular
Bjoern Simon, Jakob Neubauer, Martin Schoenthaler, Simon Hein, Fabian Bamberg, Lars Maruschke
Affiliations
Affiliations
- Department of Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [email protected].
- Department of Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Diagnostic Radiology, Pediatric Radiology and Interventional Radiology, St.-Josefs-Krankenhaus, Freiburg, Germany.
PMID: 33864536
PMCID: PMC8053137 DOI: 10.1186/s42155-021-00226-6
Abstract
BACKGROUND: Ureteroarterial fistula (UAF) is a rare but potentially life threatening disease. The aim of this study was to evaluate the outcome of endovascular therapy for UAF treatment.
METHODS: This retrospective case series evaluates a single center experience of percutaneous stent graft (SG) angioplasty and/or coil embolization for UAF. Patient follow-up included technical and early clinical success, complications and revisional procedures. We also conducted a systematic review of the literature reporting on endovascular UAF management.
RESULTS: We identified 17 UAF in 16 patients (12 male, 4 female, mean age 69.8 ± 11.3 years) who underwent endovascular UAF therapy at our tertiary hospital. All patients presented with hematuria. 5/17 (29.4%) presented with flank pain, in 7 (41.2%) cases patients were in hypovolemic shock. Risk factors of UAF included chronic indwelling ureteral stents in all fistulas, major pelvic surgery in 13 cases (76.5%). In 6 cases (35.3%) SG were placed from the common iliac artery (CIA) to the external iliac artery (EIA) following coil embolization of the proximal internal iliac artery (IIA). SG placement without previous coil embolization was performed in 10 fistulas (58.8%). In one case only coil embolization of the IIA was performed. Mean follow-up was 654 (range: 1-3269) days. All procedures were technically successful and no procedure related deaths occurred during follow-up. During the initial hospital stay hematuria disappeared in 14/17 cases (82.4%). Overall, four patients suffered recurrent hematuria, which in three cases resolved after a secondary intervention. One recurrent UAF related death occurred during follow-up 229 days after initial treatment. A total of 152 UAF cases were additionally analyzed from our systematic literature review: SG placement with or without embolization was performed in 140 cases (92.1%) while embolization alone was done in 12 cases (7.9%). Complications included UAF recurrence (18/152, 11.8%), SG thrombosis (7/140, 5%), and SG infections (5/140, 3.6%) with an overall complications rate of 13.8%. Five patients died due to UAF (3.3%).
CONCLUSION: Endovascular therapy offers high technical success rates and rapid bleeding control of UAF. Severe complications like SG occlusions or SG infections are rare but significant. Antibiotic treatment and single anti-platelet therapy improve SG durability as well as close and long follow-up to timely perform repeated endovascular or surgical treatment if necessary.
EVIDENCE-BASED MEDICINE: Level 4, case series.
Keywords: Arterioureteral fistula; Coil embolization; Endovascular therapy; Hematuria; Stent graft; Ureteral catheterization; Ureteroarterial fistula
References
- Ann Vasc Surg. 2016 Oct;36:22-27 - PubMed
- J Vasc Surg Cases Innov Tech. 2020 Apr 14;6(2):199-204 - PubMed
- Vascular. 2016 Apr;24(2):203-7 - PubMed
- J Endourol. 2018 Mar;32(3):245-251 - PubMed
- Aktuelle Urol. 2014 May;45(3):204-8 - PubMed
- J Urol. 2011 Mar;185(3):945-50 - PubMed
- Vasc Endovascular Surg. 2018 May;52(4):275-286 - PubMed
- Int Urol Nephrol. 2019 May;51(5):789-793 - PubMed
- Eur J Vasc Endovasc Surg. 2001 Sep;22(3):191-6 - PubMed
- Cardiovasc Intervent Radiol. 2017 Jun;40(6):831-835 - PubMed
- Vasa. 2021 Apr;50(3):193-201 - PubMed
- SAGE Open Med Case Rep. 2014 Aug 28;2:2050313X14548094 - PubMed
- Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381 - PubMed
- Urology. 2009 Aug;74(2):251-5 - PubMed
- Radiol Case Rep. 2021 Feb 15;16(4):968-970 - PubMed
- Cardiovasc Intervent Radiol. 2005 Mar-Apr;28(2):159-63 - PubMed
- Ann Surg. 1908 Dec;48(6):872-5 - PubMed
- J Vasc Surg. 2012 Apr;55(4):1072-80 - PubMed
- CVIR Endovasc. 2019 May 16;2(1):16 - PubMed
- Arch Ital Urol Androl. 2020 Jun 23;92(2): - PubMed
- SAGE Open Med Case Rep. 2020 Sep 28;8:2050313X20959219 - PubMed
- J Endourol Case Rep. 2020 Jun 04;6(2):73-76 - PubMed
- Tech Vasc Interv Radiol. 2009 Sep;12(3):216-21 - PubMed
- J Vasc Interv Radiol. 2006 Oct;17(10):1681-5 - PubMed
- Cureus. 2020 Jun 25;12(6):e8830 - PubMed
- Cardiovasc Revasc Med. 2017 Mar;18(2):145-150 - PubMed
- AJR Am J Roentgenol. 2015 May;204(5):W592-8 - PubMed
- BMJ Case Rep. 2020 Sep 7;13(9): - PubMed
- Urology. 2005 Nov;66(5):990-4 - PubMed
- Minim Invasive Ther Allied Technol. 2020 Jul 17;:1-9 - PubMed
- Cardiovasc Intervent Radiol. 2013 Aug;36(4):950-6 - PubMed
- J Vasc Surg Cases Innov Tech. 2019 Sep 17;5(4):396-401 - PubMed
- Radiol Case Rep. 2020 Jul 25;15(9):1714-1717 - PubMed
- AJR Am J Roentgenol. 2004 May;182(5):1241-50 - PubMed
- IJU Case Rep. 2020 Aug 30;3(6):275-277 - PubMed
Publication Types